Learn More
Medchemexpress LLC 4-naphthalen-1-yl-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline-8-sulfonamide | 353483-92-8 | MFCD01080566 | 99.8% | 376.47 g·mol⁻¹ | C22H20N2O2S | 25 MG

Supplier: Medchemexpress LLC HY10768225MG
TQS is an α7 nicotinic acetylcholine receptor positive allosteric modulator used in preclinical research to investigate neuroinflammatory pain and microglial responses. The compound is supplied as a high-purity solid and as DMSO solutions, with manufacturer-provided solubility and storage guidance for in vitro and in vivo studies.
- α7 nicotinic acetylcholine receptor positive allosteric modulator.
- High purity (>99.8%).
- Available as solid and DMSO solution for flexible dosing.
- Soluble in DMSO; in vivo formulation protocols provided.
- Stability data for powder and solutions under recommended storage conditions.
- Suitable for preclinical studies of neuroinflammatory pain and microglial activity.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.